We require a brief consultation with one of our Medical Aesthetic Specialists prior to starting Upneeq. This is to ensure you’re a good candidate for the product, as well as go through the directions and possible side effects with you. Since Upneeq is a prescription product, you will fill out a short medical history form as part of the consultation process. After your consultation you can stop by during business hours to replenish your product as needed.

YES! Contact lenses should be removed prior to instilling the drop in your eyes). Wait 15 minutes after instilling the eyedrops before putting your contact lenses back in.

Dr. Parfitt is Double Board Certified as follows:

Board of Otolaryngology-Head & Neck Surgery: aboto.org

American Board of Facial Plastic & Reconstructive Surgery: abfprs.org

He is also a Fellow Member of the American Academy of Cosmetic Surgery: cosmeticsurgery.org

See Dr. Parfitt’s full background here.

Apply 1 drop of Upneeq in each affected eye as directed, once a day

• Don’t touch eye with the tip of the vial or touch the tip of the vial to any other surface


• Throw the single-use vial away immediately after applying drops. Vials should not be re-used after opening

*Contact lens wearers should not apply Upneeq while wearing contact lenses. Upneeq should be applied before inserting your contact lenses and you should wait at least 15 minutes after application before inserting your contact lenses.

• Low-lying lids may be related to conditions such as stroke and/or brain aneurysm, Horner syndrome, myasthenia gravis, loss of the ability to move eye muscles, eye infection and eye tumors. Tell your doctor if you have any of these conditions.


• UPNEEQ is a type of medication that may affect your blood pressure. If you have heart disease, uncontrolled high or low blood pressure, or feel faint at rest or when quickly standing up, you should call your doctor if your symptoms get worse.


• Patients with reduced blood flow to the brain or heart, or patients who experience eye or mouth dryness due to an immune system disorder (Sjögren’s syndrome), should use care when taking UPNEEQ. Call your doctor immediately if you feel your symptoms may be getting worse.


• UPNEEQ may increase the risk of eye pressure due to fluid buildup (angle-closure glaucoma) in patients with untreated narrow-angle glaucoma. Call your doctor immediately if you feel increased pressure in your eye after using UPNEEQ.


• UPNEEQ belongs to a class of medication (alpha-adrenergic agonists) that may affect your blood pressure. Use UPNEEQ carefully if you currently take an alpha-adrenergic agonist medication to treat heart disease or an enlarged prostate. Patients taking beta-blockers, or other medications to treat hypertension or an abnormal heartbeat, should also be careful when using UPNEEQ.


• Patients who use a certain class of antidepressant medication (monoamine oxidase inhibitors) should also be careful when using UPNEEQ, as it may affect the way your body absorbs the medication.


• Tell your doctor if you are pregnant or plan to become pregnant before using Upneeq; it is unknown how it would affect a fetus. It is unknown if Upneeq passes into breast milk. Consult your doctor before breastfeeding.

Upneeq provides results in 15 minutes, with peak effect at 2 hours. Results may last up to 8 hours.

The most common adverse reactions with UPNEEQ (occurring in 1-5% of patients) were eye inflammation, eye redness, dry eye, blurred vision, eye pain at time of use, eye irritation, and headache.